Targeting mGlyR with nanobodies for depression
Animals All animal experiments were approved by the Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology…
Clazosentan for cerebral vasospasm prevention in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis | BMC Neurology
A total of 218 records were identified through database searches, with 134 remaining after duplicate removal. After screening…
When MOGAD mimics MS: diagnostic and therapeutic insights from a unique CNS demyelinating case | BMC Neurology
MOGAD is an immune-mediated inflammatory demyelinating disorder of the central nervous system (CNS) [5]. MOGAD is considered distinct…